109 related articles for article (PubMed ID: 1723720)
1. Synthesis and biological activity of 2-phenylethyl ester analogues of C-terminal heptapeptide of cholecystokinin modified in Trp 30 region.
Rolland M; Rodriguez M; Lignon MF; Galas MC; Laur J; Aumelas A; Martinez J
Int J Pept Protein Res; 1991 Aug; 38(2):181-92. PubMed ID: 1723720
[TBL] [Abstract][Full Text] [Related]
2. 2-Phenylethyl ester and 2-phenylethyl amide derivative analogues of the C-terminal hepta- and octapeptide of cholecystokinin.
Fulcrand P; Rodriguez M; Galas MC; Lignon MF; Laur J; Aumelas A; Martinez J
Int J Pept Protein Res; 1988 Nov; 32(5):384-95. PubMed ID: 2463231
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J
J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of some cholecystokinin analogues substituted in position 29 by a beta-alanine.
Rodriguez M; Rolland M; Lignon MF; Galas MC; Laur J; Aumelas A; Martinez J
Int J Pept Protein Res; 1989 Nov; 34(5):394-404. PubMed ID: 2482263
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity.
Galas MC; Lignon MF; Rodriguez M; Mendre C; Fulcrand P; Laur J; Martinez J
Am J Physiol; 1988 Feb; 254(2 Pt 1):G176-82. PubMed ID: 2450468
[TBL] [Abstract][Full Text] [Related]
8. A synthetic peptide derivative that is a cholecystokinin receptor antagonist.
Lignon MF; Galas MC; Rodriguez M; Laur J; Aumelas A; Martinez J
J Biol Chem; 1987 May; 262(15):7226-31. PubMed ID: 2438274
[TBL] [Abstract][Full Text] [Related]
9. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.
Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J
Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251
[TBL] [Abstract][Full Text] [Related]
10. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP
J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834
[TBL] [Abstract][Full Text] [Related]
11. Interaction of tryptophan-modified analogues of cholecystokinin-octapeptide with cholecystokinin receptors on pancreatic acini.
Adachi H; Rajh HM; Tesser GI; de Pont JJ; Jensen RT; Gardner JD
Biochim Biophys Acta; 1981 Dec; 678(3):358-63. PubMed ID: 6172157
[TBL] [Abstract][Full Text] [Related]
12. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
Gardner JD; Knight M; Sutliff VE; Jensen RT
Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 region.
Mendre C; Rodriguez M; Lignon MF; Galas MC; Gueudet C; Worms P; Martinez J
Eur J Pharmacol; 1990 Sep; 186(2-3):213-22. PubMed ID: 1705230
[TBL] [Abstract][Full Text] [Related]
14. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD
Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851
[TBL] [Abstract][Full Text] [Related]
15. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM
J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123
[No Abstract] [Full Text] [Related]
16. The importance of the amino acid in position 32 of cholecystokinin in determining its interaction with cholecystokinin receptors on pancreatic acini.
Pan GZ; Martinez J; Bodanszky M; Jensen RT; Gardner JD
Biochim Biophys Acta; 1981 Dec; 678(3):352-7. PubMed ID: 6172156
[TBL] [Abstract][Full Text] [Related]
17. Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides.
Vinayek R; Jensen RT; Gardner JD
Am J Physiol; 1987 Feb; 252(2 Pt 1):G178-81. PubMed ID: 2435164
[TBL] [Abstract][Full Text] [Related]
18. Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180.
Sato S; Stark HA; Martinez J; Beaven MA; Jensen RT; Gardner JD
Am J Physiol; 1989 Aug; 257(2 Pt 1):G202-9. PubMed ID: 2475030
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic photoaffinity labeling probes for cholecystokinin (CCK)-gastrin family receptors. D-Tyr-Gly-[Nle28,31,pNO2-Phe33)CCK-26-33).
Powers SP; Fourmy D; Gaisano H; Miller LJ
J Biol Chem; 1988 Apr; 263(11):5295-300. PubMed ID: 2451666
[TBL] [Abstract][Full Text] [Related]
20. The importance of the amino acid in position 27 of cholecystokinin in determining its biological activity on pancreatic acini.
Gardner JD; Walker MD; Martinez J; Priestly GP; Natarajan S; Bodanszky M
Biochim Biophys Acta; 1980 Jul; 630(3):323-9. PubMed ID: 6156709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
